Нові молекулярні можливості в діагностиці та прогнозуванні захворювань, асоційованих з вірусом папіломи людини у цервікальному виділенні
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Анотація
У статті визначена значущість систематичного аналізу даних, які є в сучасних публікаціях, про молекулярні маркери цервікального виділення у діагностиці різних захворювань шийки матки, асоційованих з вірусом папіломи людини (ВПЛ). Крім того, представлені перспективи вивчення білкового та метаболічного профілів цервіковагінального виділення для передбачення перебігу неопластичних процесів шийки матки. Описано низку білкових маркерів у цервікальному виділенні для своєчасної діагностики передракових захворювань та раку шийки матки.
##plugins.themes.bootstrap3.article.details##
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Автори зберігають авторське право, а також надають журналу право першого опублікування оригінальних наукових статей на умовах ліцензії Creative Commons Attribution 4.0 International License, що дозволяє іншим розповсюджувати роботу з визнанням авторства твору та першої публікації в цьому журналі.
Посилання
Venkataraman N. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid / A.L. Cole, P. Svoboda, J. Pohl, A.M. Cole // J. Immunol. – 2005. – V. 175 (11). – P. 7560-7.
Di Quinzio M.K. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins / K. Oliva, S.J. Holdsworth, M. Ayhan, S.P. Walker, G.E. Rice et al. //Aust. N. Z. J. Obstet. Gynaecol. – 2007. – V. 47 (1). – P. 9-15.
Heng Y.J. Interleukin-1 receptor antagonist in human cervicovaginal fluid in term pregnancy and labor /M.K. Di Quinzio, M. Permezel, G.E. Rice, H.M. Georgiou // Am. J. Obstet. Gynecol. – 2008. – V. 199 (6). – P. 656-73. e1-7.
Dasari S. Comprehensive proteomic analysis of human cervical-vaginal fluid // L. Pereira, A.P. Reddy, J.E. Michaels, X. Lu, T. Jacob et al. // J. Proteome Res. – 2007. – V. 6 (4). – P. 1258-68.
Shaw J.L. Proteomic analysis of human cervico-vaginal fluid / C.R. Smith, E.P. Diamandis // J. Proteome Res. – 2007. – V. 6 (7). – P. 2859-65.
Tang L.J. Proteomic analysis of human cervical-vaginal fluids / S.F. De, F. Odreman, P. Venge, C. Piva, S. Guaschino, R.C. Garcia // J. Proteome Res. – 2007. – V. 6 (7). – P. 2874-83.
Zegels G. Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples / G.A. Van Raemdonck, E.P. Coen, W.A. Tjalma, X.W. Van Ostade // Proteome Sci. – 2009. – V. 7. – P. 17.
Andersch-Bjorkman Y. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle / K.A. Thomsson, J.M. Holmen Larsson, E. Ekerhovd, G.C. Hansson // Mol. Cell. Proteomics. – 2007. – V. 6 (4). – P. 708-16.
Panicker G. Characterization of the human cervical mucous proteome / Y. Ye, D. Wang, E.R. Unger // Clin. Proteomics. – 2010. – V. 6 (1–2). – P. 18-28.
Ding T. Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women / X. Wang, F. Ye, X. Cheng, D. Ma, W. Lu, X. Xie // Gynecol. Oncol. – 2010. – V. 119 (3). – P. 436-43.
Zardiashvili M.D. Molecular markers of cervicovaginal fluid: a new in the diagnosis and prognosis of diseases associated with human papilloma virus / N.M. Nazarova, N.L. Starodubtseva, A.E. Bugrova, E. Frankevich, V.N. Prilepskaya // Obstetrics and gynecology. – 2016. – V. 1. – P. 16-21.
Van Ostade X. Analysis of cervico-vaginal fluid from precancerous women points to the presence of biomarkers for the precancerous state of cervical carcinoma / D. Martin, G. Raemdonck // Proteomes. – 2014. – V. 2 (3). – P. 426-50. doi: 10.3390/proteomes2030426.
Schiffman M. Human papillomavirus and cervical cancer // P.E. Castle, J. Jeronimo, A.C. Rodriguez, S. Wacholder // Lancet. – 2007. – V. 370 (9590). – V. 890-907.
Kroeger K.M. The 308 tumor necrosis factor-alpha promoter polymorphism effects transcription / K.S. Carville, L.J. Abraham // Mol. Immunol. – 1997. – V. 34 (5). – P. 391-9.
Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers – United States, 2004–2008 // MMWR Morb. Mortal Wkly Rep. – V. 61 (15). – P. 258-61.
Guidelines for the diagnosis and treatment of human papillomavirus infections of the female genital tract. The official publication of the European Society for infectious diseases in obstetrics and gynecology // European J. Inr. Immunol. Dis. Obstet. Gynaecol. – 2001. – V. 4, 5. – Suppl. 21.
Wheeler C.M. Human papillomavirus genotypes and the cumulative 2-years risk of cervical precancer / W.C. Hunt, M. Schiffman, P.E. Castle // J. Infect. Dis. – 2006. – V. 194 (9). – P. 1291-9.
Van Raemdonck G.A. Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid / W.A. Tjalma, E.P. Coen, C.E. Depuydt, X.W. Van Ostade // PLoS One. – 2014. – V. 9 (9). – P.e106488.
Scheffner M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 / M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, P.M. Howley // Cell. – 1990. – V. 63 (6). – P. 1129-36.
Roman A. The papillomavirus E7 proteins / A. Roman, K. Munger // Virology. – 2013. – V. 445 (1–2). – P. 138-68.
Ullal A. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia / M. Roberts, J.N. Bulmer, M.E. Mathers, V. Wadehra // Cytopathology. – 2008. – V. 20 (6). – P. 359-66.
Pereira P.M. MicroRNA expression variability in human cervical tissues / J.P. Marques, A.R. Soares, L. Carreto, M.A. Santos // PLoS One. – 2010. – V. 5 (7). – P.e11780.
Quayle A.J. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J. Reprod. Immunol. – 2002. – V. 57(1–2). – P. 61-79.
Ochiel D.O. Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens / J.V. Fahey, M. Ghosh, S.N. Haddad, C.R. Wira // Curr Womens Health Rev. – 2008. – V. 4 (2). – P. 102-17.
Iijima N. Dendritic cells and macrophages in the genitourinary tract / J.M. Thompson, A. Iwasaki // Mucosal Immunol. – 2008. – V. 1 (6). – P. 451-9.
Eschenbach D.A. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora / S.S. Thwin, D.L. Patton, T.M. Hooton, A.E. Stapleton, K. Agnew et al. // Clin. Infect. Dis. – 2000. – 30 (6). – P. 901-7.
Valore E.V. Antimicrobial components of vaginal fluid / C.H. Park, S.L. Igreti, T. Ganz // Am. J. Obstet. Gynecol. – 2002. – V. 187 (3). – P. 561-8.
Cole A.M. Innate host defense of human vaginal and cervical mucosae / Curr. Top. Microbiol. Immunol. – 2006. – V. 306. – P. 199-230.
Rohan L.C. Vaginal drug delivery systems for HIV prevention / A.B. Sassi // AAPS J. – 2009. – V. 11 (1). – P. 78-87.
Wira C.R. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection / K.S. Grant-Tschudy, M.A. Crane-Godreau //Am. J. Reprod. Immunol. – 2005. – V. 53 (1). – P. 65-76.
Klein L.L. Shotgun proteomic analysis of vaginal fluid from women in late pregnancy / K.R. Jonscher, M.J. Heerwagen, R.S. Gibbs, J.L. McManaman // Reprod. Sci. – 2008. – V. 15 (3). – P. 263-73.
Zegels G. Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract / G.A. Van Raemdonck, W.A. Tjalma, X.W. Van Ostade // Proteome Sci. – 2010. – V. 8. – P. 63.
Thomas P.D., PANTHER: a library of protein families and subfamilies indexed by function / M.J. Campbell, А. Kejariwal, Н. Mi, В. Karlak, R. Daverman et al. // Genome Res. 2003. – V. 13 (9). – P. 2129-41.
Good D.M. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future / V. Thongboonkerd, J. Novak, J.L. Bascands, J.P. Schanstra, J.J. Coon et al. // J. Proteome Res. – 2007. – V. 6 (12). – P. 4549-55.
Veenstra T.D. Biomarkers: mining the biofluid proteome / T.P. Conrads, B.L. Hood, A.M. Avellino, R.G. Ellenbogen, R.S. Morrison // Mol. Cell. Proteomics. – 2005. – V. 4 (4). – P. 409-18.
Hu S. Human body fluid proteome analysis / J.A. Loo, D.T. Wong // Proteomics. – 2006. – V. 6 (23). – P. 6326-53.
Schmidt A. High-accuracy proteome maps of human body fluids / R. Aebersold // Genome Biol. – 2006. – V. 7 (11). – P. 242.
Novak R.M. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection / B.A. Donoval, P.J. Graham, L.A. Boksa, G. Spear, R.C. Hershow et al. // Clin. Vaccine Immunol. – 2007. – V. 14 (9). – P. 1102-7.
Wiesenfeld H.C. Association between elevated neutrophil defensin levels and endometritis / R.P. Heine, M.A. Krohn, S.L. Hillier, A.A. Amortegui, M. Nicolazzo, R.L. Sweet // J. Infect. Dis. – 2002. – V. 186 (6). – P. 792-7.
Xu J. Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery / C.B. Holzman, C.G. Arvidson, H. Chung, A.R. Goepfert // Obstet. Gynecol. – 2008. – V. 112 (3). – P. 524-31.
St John E. Bacterial vaginosis and host immunity / D. Mares, G.T. Spear // Curr. HIV/AIDS Rep. – 2007. – V. 4 (1). – P. 22-8.
Spear G.T. Bacterial vaginosis and human immunodeficiency virus infection / E. St John, M.R. Zariffard // AIDS Res. Ther. – 2007. – V. 4. – P. 25.
Wira C.R. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle / J.V. Fahey // AIDS. – 2008. – V. 22 (15). – P. 1909-17.
Meng W. Human в-defensin messenger RNA is overexpressed in the cervical epithelia of patients with non-gonococcal cervicitis / R. Du, Y. Wang, Z. Chen, Y. Ding // J. Low Genit. Tract. Dis. – 2013. – V. 17 (4). – P. 440-5.
Shimoya K. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women / Q. Zhang, K. Temma, T. Kimura, T. Tsujie, T. Tsutsui at al / Maturitas. – 2006. – V. 54 (2). – P. 141-8.
Ildgruben A. Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage / I. Sjöberg, M.L. Hammarström, T. Bäckström // Contraception. – 2005. – V. 72 (5). – P. 383-92.
Ildgruben A.K. Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium / I.M. Sjöberg, M.L. Hammarström // Obstet. Gynecol. – 2003. – V. 102 (3). – P. 571-82.
Prevention of cervical cancer: a Guide for physicians. – M.: Medpress-inform. – 2007. – P. 56.
Solomon D. The 2001 Bethesda System. Terminaligy for reporting results of cervical cytology / D. Davey, R. Kurman et al. // JAMA. – 2002. – V. 16. – P. 2114-2118.
Ibeanu OA. Molecular pathogenesis of cervical cancer. Cancer Biology and Therapy. – 2011. – V. 11 (3). – P. 295-306.
http://megaslides.com/doc/794253/lekciya-vospalitelnye-zabolevaniya-zhenskih-polovyh-organov
